Icon Advisers’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-15,100
Closed -$1.47M 246
2020
Q2
$1.47M Sell
15,100
-2,644
-15% -$246K 0.29% 123
2020
Q1
$1.47M Hold
17,744
0.32% 107
2019
Q4
$1.97M Hold
17,744
0.28% 126
2019
Q3
$1.76M Sell
17,744
-47,705
-73% -$4.74M 0.26% 133
2019
Q2
$6.49M Sell
65,449
-7,300
-10% -$697K 0.61% 47
2019
Q1
$8.02M Sell
72,749
-47,209
-39% -$4.93M 0.81% 35
2018
Q4
$11M Sell
119,958
-4,400
-4% -$445K 1.16% 23
2018
Q3
$13.7M Sell
124,358
-48,752
-28% -$5.08M 1.16% 20
2018
Q2
$16.2M Hold
173,110
1.22% 21
2018
Q1
$14.4M Buy
173,110
+19,568
+13% +$1.74M 1.09% 23
2017
Q4
$14M Buy
153,542
+113,042
+279% +$9.4M 0.97% 27
2017
Q3
$3.08M Buy
40,500
+26,200
+183% +$1.98M 0.22% 136
2017
Q2
$1.07M Sell
14,300
-7,000
-33% -$485K 0.07% 270
2017
Q1
$1.39M Buy
+21,300
New +$1.25M 0.1% 246

Other funds holding PRAH

Icon Advisers's PRAH Position: Q3 2020 in Review

Icon Advisers sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 15,100 shares — an estimated $1.47M sold.

Icon Advisers first reported a position in PRAH in Q1 2017 and held it in 14 quarters. The position peaked at $16.2M in Q2 2018. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

  • Icon Advisers reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Icon Advisers sold 15,100 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $1.47M.
  • Icon Advisers first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 14 quarters.
  • Icon Advisers's PRA Health Sciences, Inc. position peaked at $16.2M in Q2 2018.
  • 281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on Icon Advisers's 13F filing for Q3 2020, filed 5 Nov 2020.